Earlier, we were talking about the choice of antivirals. According to Danielle Grondin, of Health Canada, we still do not know how many injections will be needed to protect people against H1N1. In 80% of cases, Tamiflu will be used. Yet some studies done abroad suggest that Tamiflu could lead to complications—in children, for instance.
Some are expressing concerns about the choice of antivirals. Could you tell us overall why that is the case?